Share Email Print
cover

Proceedings Paper

Hyperspectral imaging system to discern malignant and benign canine mammary tumors
Author(s): Amrita Sahu; Cushla McGoverin; Nancy Pleshko; Karin Sorenmo; Chang-Hee Won
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Hyperspectral imaging is an emerging technology in the field of biomedical engineering which may be used as a noninvasive modality to characterize tumors. In this paper, a hyperspectral imaging system was used to characterize canine mammary tumors of unknown histopathology (pre-surgery) and correlate these results with the post-surgical histopathology results. The system consisted of a charge coupled device (CCD) camera, a liquid crystal tunable filter in the near infrared range (650-1100 nm) and a controller. Spectral signatures of malignant and benign canine mammary tumors were extracted and analyzed. The reflectance intensities of malignant tumor spectra were generally lower than benign tumor spectra over the entire wavelength range. Previous studies have shown that cancerous tissues have a higher hemoglobin and water content, and lower lipid concentration with respect to benign tissues. The decreased reflectance intensity observed for malignant tumors is likely due to the increased microvasculature and therefore higher blood content of malignant tissue relative to benign tissue. Peaks at 700, 840, 900 and 970 nm were observed in the second derivative absorption spectra, these peaks were attributed to deoxy-hemoglobin, oxy-hemoglobin, lipid and water respectively. A ‘Tissue Optical Index’ was developed that enhances contrast between malignant and benign canine tumors. This index is based on the ratio of the reflectance intensity values corresponding to the wavelengths associated with the four chromophores. Preliminary results from 22 canine mammary tumors showed that the sensitivity and specificity of the proposed method is 85.7% and 94.6% respectively. These results show promise in the non-invasive optical diagnosis of canine mammary cancer.

Paper Details

Date Published: 31 May 2013
PDF: 8 pages
Proc. SPIE 8719, Smart Biomedical and Physiological Sensor Technology X, 87190W (31 May 2013); doi: 10.1117/12.2015836
Show Author Affiliations
Amrita Sahu, Temple Univ. (United States)
Cushla McGoverin, Temple Univ. (United States)
Nancy Pleshko, Temple Univ. (United States)
Karin Sorenmo, Univ. of Pennsylvania (United States)
Chang-Hee Won, Temple Univ. (United States)


Published in SPIE Proceedings Vol. 8719:
Smart Biomedical and Physiological Sensor Technology X
Brian M. Cullum; Eric S. McLamore, Editor(s)

© SPIE. Terms of Use
Back to Top